Cantitate/Preț
Produs
Total produse
Vezi coșul
Pulmonary Pharmacology de W.S Fred Wong

Pulmonary Pharmacology: Advances in Pharmacology, cartea 98

W.S Fred Wong
en Limba Engleză Hardback – 31 iul 2023
Pulmonary Pharmacology, Volume 98 provides in-depth reviews on the latest progresses about respiratory drug discovery and development. Topics covered in this volume include corticosteroids, monoclonal antibodies, tyrosine kinase inhibitors and phosphodiesterase inhibitors for the treatments of asthma, COPD or pulmonary fibrosis, with perspective on the development of novel therapeutic strategies such as renin-angiotensin system modulators, mitochondrial function modulators, and non-antibacterial macrolides. Part of the volume is devoted to senotherapy for lung ageing in respiratory diseases, and novel pulmonary delivery technologies, including inhaled biologics.


  • Provides accurate reviews from leading experts on the topic of pulmonary pharmacology
  • Each chapter of the volume provides consolidated graphical materials for ease of reading for the audience
  • Provides the latest insights and future perspectives on the drug discovery and development for respiratory diseases
Citește tot Restrânge

Din seria Advances in Pharmacology

Preț: 106673 lei

Preț vechi: 142932 lei
-25% Nou

Puncte Express: 1600
Preț estimativ în valută:
20413€ • 21475$ • 16901£

Carte tipărită la comandă

Livrare economică 07-21 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443188800
ISBN-10: 0443188807
Pagini: 334
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology

Public țintă

Biomedical scientists, clinicians, and medicinal chemists in drug discovery and developing, pathophysiology or pharmaceutics, who are particularly interested in respiratory diseases such as asthma, COPD and pulmonary fibrosis

Cuprins

Preface W.S. FRED WONG 1. Genomic and non-genomic effects of glucocorticoids in respiratory diseases Zhao-Yong Lee and Thai Tran 2. Recent developments in the use of monoclonal antibodies targeting the type 2 cytokines for severe asthma treatment Garry M. Walsh 3. Phosphodiesterase inhibitors and lung diseases Ivana Stolfa and Clive Page 4. Prospects for macrolide therapy of asthma and COPD Michael J. Parnham, Virginia Norris, Jennifer A. Kricker, Thorarinn Gudjonsson, and Clive P. Page 5. Targeting the renin angiotensin system for respiratory diseases Phyllis X.L. Gan, W. Liao, Kira M. Linke, D. Meid, X.D. Wu, and W.S. Fred Wong 6. Progress in the development of kinase inhibitors for treating asthma and COPD Nathaniel McClean, Jeffery D. Hasday, and Paul Shapiro 7. Anti-fibrotic strategies and pulmonary fibrosis Avanka Gunatilaka, Stephanie Zhang, Wan Shun Daniel Tan, and Alastair G. Stewart 8. Novel treatments against airway inflammation in COPD based on drug repurposing Rui Chen, Yuting Cui, and Judith C.W. Mak 9. Senotherapy for lung diseases Peter J. Barnes 10. Delivery technology of inhaled therapy for asthma and COPD Michael Y.T. Chow, Harry W. Pan, and Jenny K.W. Lam